Moonlake Therapeutics’ Nasdaq share offering: a news article about a Swiss biotech’s recent public fundraising and its planned corporate uses.
Key Takeaways
- Find everything from accelerators to investors and meet like-minded people in thestartup community
- Issue and sale of the option shares were completed this week, increasing the total by USD 30 million
- All of the securities to be sold in the offering are being offered by MoonLake